AAAAAA
Results:
1-19
|
Results: 19
Authors:
Bastian, I
Portaels, F
Citation: I. Bastian et F. Portaels, Introduction - Multidrug-resistant tuberculosis: past, present and future, RESURG EMER, 1, 2000, pp. 1-15
Authors:
Moore, M
McCray, E
Onorato, IM
Citation: M. Moore et al., The epidemiology of multidrug-resistant tuberculosis in the United States and other established market economies, RESURG EMER, 1, 2000, pp. 17-28
Authors:
Espinal, MA
Citation: Ma. Espinal, Epidemiology of multidrug-resistant tuberculosis in low- and middle-incomecountries, RESURG EMER, 1, 2000, pp. 29-44
Authors:
McCray, E
Onorato, IM
Citation: E. Mccray et Im. Onorato, The interaction of human immunodeficiency virus and multidrug-resistant Mycobacterium tuberculosis, RESURG EMER, 1, 2000, pp. 45-57
Authors:
Pablos-Mendez, A
Lessnau, K
Citation: A. Pablos-mendez et K. Lessnau, Clinical mismanagement and other factors producing antituberculosis drug resistance, RESURG EMER, 1, 2000, pp. 59-76
Authors:
Takiff, HE
Citation: He. Takiff, The molecular mechanisms of drug resistance in Mycobacterium tuberculosis, RESURG EMER, 1, 2000, pp. 77-114
Authors:
Raviglione, MC
Citation: Mc. Raviglione, DOTS and multidrug-resistant tuberculosis, RESURG EMER, 1, 2000, pp. 115-131
Authors:
Heifets, L
Citation: L. Heifets, Conventional methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis, RESURG EMER, 1, 2000, pp. 133-143
Authors:
Palomino, JC
Citation: Jc. Palomino, Novel rapid antimicrobial susceptibility tests for Mycobacterium tuberculosis, RESURG EMER, 1, 2000, pp. 145-162
Authors:
Peloquin, CA
Auclair, B
Citation: Ca. Peloquin et B. Auclair, Pharmacology of the second-line antituberculosis drugs, RESURG EMER, 1, 2000, pp. 163-174
Authors:
Iseman, MD
Huitt, GA
Citation: Md. Iseman et Ga. Huitt, Treatment of multidrug-resistant tuberculosis, RESURG EMER, 1, 2000, pp. 175-190
Authors:
Crofton, J
Van Deun, A
Citation: J. Crofton et A. Van Deun, Treatment of multidrug-resistant tuberculosis in developing countries, RESURG EMER, 1, 2000, pp. 191-203
Authors:
Telzak, EE
Citation: Ee. Telzak, Treatment outcome of multidrug-resistant tuberculosis, RESURG EMER, 1, 2000, pp. 205-212
Authors:
Stapledon, RA
Lumb, R
Lim, IS
Citation: Ra. Stapledon et al., Chemoprophylaxis and BCG in contacts of multidrug-resistant tuberculosis, RESURG EMER, 1, 2000, pp. 213-224
Authors:
Weinstock, DM
Sepkowitz, KA
Citation: Dm. Weinstock et Ka. Sepkowitz, Multidrug-resistant tuberculosis and the health care worker, RESURG EMER, 1, 2000, pp. 225-239
Authors:
Barry, CE
Citation: Ce. Barry, The development of new chemotherapeutics for multidrug-resistant tuberculosis, RESURG EMER, 1, 2000, pp. 241-252
Authors:
Dye, C
Williams, BG
Citation: C. Dye et Bg. Williams, Population dynamics and control of multidrug-resistant tuberculosis, RESURG EMER, 1, 2000, pp. 253-267
Authors:
Richards, C
Jarvis, WR
Citation: C. Richards et Wr. Jarvis, Administrative, engineering, and personal protective measures for controlling Mycobacterium tuberculosis, RESURG EMER, 1, 2000, pp. 269-284
Authors:
Farmer, PE
Shin, SS
Bayona, J
Kim, JY
Furin, JJ
Brenner, JG
Citation: Pe. Farmer et al., Making DOTS-Plus work, RESURG EMER, 1, 2000, pp. 285-306
Risultati:
1-19
|